I thought that might be him, and I think it's lovely that he's here supporting you today, considering everything he's had to see you go through.
Madam Brill-Edwards, I just want to share a small anecdote with you. Ms. Gualtieri will know that I do this. I spent the summer of 2000 at Merck Pharmaceuticals in Whitehouse Station—the summer between the two years of my MBA—and that was when Vioxx was all the rage. I remember seeing the marketing department. Everyone was completely on fire for this drug. Lo and behold, that fall would begin the downfall as that evidence became public and as America and the world became aware of the fallout of that.
Ms. Gualtieri, I know you mentioned that, so I'm just saying that I've seen what you're describing.
Madam Myers, I'm always very big on comparative studies. You gave the example of the European Union. If I was conducting a comparative study on which we could base our new whistle-blower protection, could you provide me with the top international resources on that? You mentioned the European Union, but if you could provide a short, comprehensive list, please....